- Tytuł:
- Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
- Autorzy:
- Źródło:
- In The Lancet Neurology February 2023 22(2):127-136
Czasopismo naukowe